Regarding the critical role of Ras/ERK1/2 in cell growth advantages [27], the aforementioned results elucidate the significance of ILK in cell growth advantages, at least in gastric cancers, through a non-canonical mechanism involving the facilitation of ERK1/2 activation. The gene discussed is MAPK3; the disease is gastric cancer.